دورية أكاديمية
أعرض في EDS

Cardiovascular risk assessment in Portugal's primary health care system: SCORE vs. SCORE2.

التفاصيل البيبلوغرافية
العنوان: Cardiovascular risk assessment in Portugal's primary health care system: SCORE vs. SCORE2.
المؤلفون: Silva C; USF Mondego, ACeS Baixo Mondego, Coimbra, Portugal. Electronic address: m.cristina.silva.26@gmail.com., Mendes JE; USF Fernando Namora, ACeS Baixo Mondego, Coimbra, Portugal., Ramos R; USF Fernando Namora, ACeS Baixo Mondego, Coimbra, Portugal., Gaspar A; USF Fernando Namora, ACeS Baixo Mondego, Coimbra, Portugal., Leal F; USF Fernando Namora, ACeS Baixo Mondego, Coimbra, Portugal., Mendes N; USF Fernando Namora, ACeS Baixo Mondego, Coimbra, Portugal.
المصدر: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology [Rev Port Cardiol] 2024 Aug; Vol. 43 (8), pp. 449-455. Date of Electronic Publication: 2024 Feb 21.
نوع المنشور: Journal Article; Comparative Study
اللغة: English; Portuguese
بيانات الدورية: Publisher: Lisbon Country of Publication: Portugal NLM ID: 8710716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2174-2030 (Electronic) Linking ISSN: 08702551 NLM ISO Abbreviation: Rev Port Cardiol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2011- : Lisbon : Elsevier
Original Publication: Lisboa : Sociedade Portuguesa De Cardiologia
مواضيع طبية MeSH: Primary Health Care*/statistics & numerical data , Cardiovascular Diseases*/epidemiology, Humans ; Male ; Middle Aged ; Portugal/epidemiology ; Female ; Cross-Sectional Studies ; Risk Assessment/methods ; Aged ; Adult
مستخلص: Introduction and Objectives: The 2021 European Society of Cardiology guidelines on cardiovascular disease (CVD) prevention introduced the more accurate SCORE2 risk model as a replacement for the earlier SCORE, which is still used in primary care software in Portugal. Our objective is to determine whether the difference between risk assessment using SCORE and SCORE2, in the same patient population, is statistically significant.
Methods: A total of 1642 patients aged 40-65 without previous CVD, from the medical records of two Family Health Units, were included in this cross-sectional study. SCORE and SCORE2 were calculated using the variables gender, age, smoking status, lipid profile and systolic blood pressure. A statistical analysis was performed on the results.
Results: Using SCORE, 98% of the patients were in the low-moderate risk categories and 2% in the high or very high risk categories. When using SCORE2, the corresponding percentages were 55% and 45%, respectively. Reclassification with SCORE2 into higher categories was more often observed in younger (under 50 years of age) and male patients. With SCORE, 38.61% of patients were within the LDL-C target range; this figure fell to 20.28% with SCORE2. These differences are statistically significant (p<0.0001).
Conclusion: Our findings show that a significant number of patients in this cohort who were classified through SCORE at lower risk levels were reclassified into higher risk categories with SCORE2. Similarly, the number of patients within the LDL-C target range for LDL-C was also lower using SCORE2.
(Copyright © 2024 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.)
فهرسة مساهمة: Keywords: Avaliação do risco cardiovascular; Cardiovascular disease; Cardiovascular risk assessment; Doença cardiovascular; Prevenção primária; Previsão do risco; Primary prevention; Risk prediction; SCORE; SCORE2
تواريخ الأحداث: Date Created: 20240223 Date Completed: 20240729 Latest Revision: 20240729
رمز التحديث: 20240730
DOI: 10.1016/j.repc.2023.10.012
PMID: 38395300
قاعدة البيانات: MEDLINE
الوصف
تدمد:2174-2030
DOI:10.1016/j.repc.2023.10.012